Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
Abstract
Diabetes mellitus (DM) is a critical risk factor for avoidable blindness globally, primarily due to diabetic retinopathy (DR), an ocular condition with serious implications if left unmanaged. The risk of DR progression is closely linked to diabetes duration, blood glucose control, and other modifiable factors like blood pressure, hyperlipidemia, and smoking. While laser photocoagulation has been the conventional treatment, advances have integrated pharmacotherapy and early surgical interventions. Multiple studies, including the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) and the EURODIAB Prospective Complications Study, have underscored the influence of diabetes duration, HbA1c levels, and early onset on DR progression. Despite extensive research in type 1 diabetes, studies on type 2 diabetes, particularly for patients with over 20 years since diagnosis, are limited. This study examines the prevalence of DR and other ocular complications in type 2 DM patients with prolonged disease duration. Findings from global studies emphasize the need for effective metabolic control to mitigate DR progression. This investigation highlights the substantial public health burden posed by DR, underscoring the necessity of modifiable risk management to preserve ocular health in diabetic patients.
How to cite this article:
Bijan Mallick and Suchandra Das. Evaluation of Ocular Changes in Patients with Type-2 Diabetes Mellitus with More than 20 Years of Disease Duration.
DOI: https://doi.org/10.36478/10.59218/makrjms.2024.8.18.685.701
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2024.8.18.685.701